Catalyst Wire Dossier Catalyst Wire Dossier

Donepezil SR 23 mg

donepezil · Eisai Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Donepezil SR 23 mg, covering 2012-06-19 to 2012-06-19. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease [Phase 3]

See pricing